• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cytogenetic heterogeneity in blast crisis (BC) of chronic myelogenous leukemia (CML).

作者信息

Abramson J, Verma R S, Schwartz J

出版信息

Blut. 1985 Nov;51(5):361-3. doi: 10.1007/BF00320047.

DOI:10.1007/BF00320047
PMID:3864501
Abstract

New cytogenetic findings are reported in a patient who entered into an accelerated blastic phase of chronic myelogenous leukemia (CML). The cytogenetic findings of this case can be described as 46, xy, t (5;7) (q 31;q 11), t (9;22) (q 34;q 11), Ph'. The prognostic implications in such patients with rare and unusual cytogenetic findings are discussed.

摘要

相似文献

1
Cytogenetic heterogeneity in blast crisis (BC) of chronic myelogenous leukemia (CML).
Blut. 1985 Nov;51(5):361-3. doi: 10.1007/BF00320047.
2
Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.Ph1阳性慢性髓性白血病急变期的(4p+;6q-)和(12q-;Xp+)易位
Blut. 1984 Oct;49(4):325-30. doi: 10.1007/BF00320206.
3
Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.慢性粒细胞白血病中的Ph1易位变异及其发生率,包括两例先后发生淋巴细胞危象和髓细胞危象的病例。
Cancer Genet Cytogenet. 1982 Mar;5(3):187-201. doi: 10.1016/0165-4608(82)90025-5.
4
Complex translocation t(3;9;22) and paracentric inversion of chromosome 3 in blastic crisis of chronic myeloid leukemia.
Cancer Genet Cytogenet. 1986 Feb 15;20(3-4):305-9. doi: 10.1016/0165-4608(86)90088-9.
5
Unusual Ph translocations in CML: four new cases.慢性粒细胞白血病中不寻常的Ph染色体易位:4例新病例
Cancer Genet Cytogenet. 1985 Feb 15;15(3-4):199-207. doi: 10.1016/0165-4608(85)90163-3.
6
Near-haploid cell line in the blastic crisis of chronic myelogenous leukemia: a possible marker for lymphoid malignancy.慢性粒细胞白血病急变期的近单倍体细胞系:一种可能的淋巴系恶性肿瘤标志物。
Cancer Genet Cytogenet. 1983 Aug;9(4):333-9. doi: 10.1016/0165-4608(83)90081-x.
7
A t (11;21) (13;q22) in Ph-positive chronic myelogenous leukemia.费城染色体阳性慢性髓性白血病中的t(11;21)(13;q22)
Cancer Genet Cytogenet. 1988 Apr;31(2):187-91. doi: 10.1016/0165-4608(88)90216-6.
8
Nonrandom chromosome rearrangements in 27 cases of human myeloid leukemia.27例人类髓系白血病中的非随机染色体重排
Hum Genet. 1977 Dec 23;39(3):293-301. doi: 10.1007/BF00295422.
9
Chromosomal anomaly of 6q in chronic myelogenous leukemia (CML).慢性粒细胞白血病(CML)中6号染色体长臂的染色体异常。
Cancer Genet Cytogenet. 1981 Mar;3(2):131-6. doi: 10.1016/0165-4608(81)90067-4.
10
Promyelocytic blast crisis of chronic myelocytic leukemia with both t(9;22) and t(15;17) in M3 cells.
Cancer. 1984 Dec 1;54(11):2409-13. doi: 10.1002/1097-0142(19841201)54:11<2409::aid-cncr2820541117>3.0.co;2-v.

本文引用的文献

1
Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases.
Scand J Haematol. 1982 Feb;28(2):103-17. doi: 10.1111/j.1600-0609.1982.tb00502.x.
2
Prognostic value of chromosomal findings in the blast phase of Ph1-positive chronic myeloid leukaemia (CML).Ph1阳性慢性髓性白血病(CML)急变期染色体检查结果的预后价值
Int J Cancer. 1981 Mar 15;27(3):287-95. doi: 10.1002/ijc.2910270306.
3
Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.Ph1阳性慢性髓性白血病急变期的(4p+;6q-)和(12q-;Xp+)易位
Blut. 1984 Oct;49(4):325-30. doi: 10.1007/BF00320206.
4
Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.Ph1 阳性慢性髓性白血病急变期初始染色体检查结果的治疗及预后价值
Blood. 1983 May;61(5):935-9.
5
Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.慢性粒细胞白血病的原始细胞危象。形态学变异及其治疗意义。
Am J Med. 1977 Oct;63(4):542-7. doi: 10.1016/0002-9343(77)90199-1.
6
A simple R banding technic.一种简单的R显带技术。
Am J Hum Genet. 1975 Jan;27(1):110-7.